Urological Catheters Market Outlook: Growth in Urological Incontinence to Drive Market Growth to US$ 13.34 Billion by 2033

As per the latest market research by Business Market Insights (BMI), the research report "Urological Catheters Market Outlook Size and Forecast (2022–2033)" forecasts how the market is set to surge 101.1% by 2033 as rise in urological incontinence cases reshapes the urological catheters ecosystem. The report highlights technological advancements in connected catheters, revolutionizing the global landscape of urological catheters.

The report forecasts the market to expand from US$ 6.63 billion in 2024 to US$ 13.34 billion by 2033, registering a robust CAGR of 8.07% over the 2025–2033 period.

Technological innovations in connected catheters are one of the major factors that are changing the global market landscape for urological catheters by making these devices intelligent healthcare solutions. Connected catheters combine sensors, wireless communication, and data analytics to measure urine flow, detect infection at the early stages, and provide real, timely feedback to healthcare providers and patients. This new technology confronts the problem of catheter such as associated infections, which is one of the most urgent problems of urology, by making it possible to perform intervention in a proactive manner and thus, decrease patient visits to the hospital. Connected catheters provide patients with good quality of life and security as well as giving them personalized insight that are helpful in management of chronic conditions like urinary incontinence or neurogenic bladder. The healthcare professionals get continuous data which aids in their decision making, help them optimize treatment plans, and reduce the burden of manual monitoring. Such improvements in technology are in line with prevailing and broader digital health trends where telemedicine and remote monitoring are becoming indispensable in care provision. Connected catheters are seen as cost-effective solutions that not only raise healthcare outcomes but also reduce long term healthcare expenses. This is a global scenario of adoption that is forecasted to be accelerated by manufacturers. ​‍​‌‍​

Overview of report findings

Market Growth

The Urological Catheters Market is projected to grow from US$ 6.63 billion in 2024 to US$ 13.34 billion by 2033, registering a compound annual growth rate (CAGR) of 8.07% between 2025 and 2033.

The growth in the cases of urinary incontinence and increasing adoption of hydrophilic‑coated catheters are key factors propelling market growth. Advancements in connected catheters are transforming the landscape of urological catheters.

Growing Cases of Urinary Incontinence

The rising prevalence of urinary incontinence is a significant factor driving growth in the urological catheters market. Urinary incontinence, which affects millions of people worldwide, is closely linked to aging populations, lifestyle changes, and the increasing incidence of chronic conditions such as diabetes, obesity, and neurological disorders. As the number of patients experiencing bladder control issues continues to grow, the demand for effective management solutions has expanded rapidly. Urological catheters, particularly intermittent and indwelling types, provide a reliable means of addressing incontinence by ensuring bladder emptying and improving patient comfort. Hospitals, long‑term care facilities, and rehabilitation centers are witnessing higher catheter utilization as they manage elderly patients and those recovering from surgery or trauma. Moreover, awareness campaigns and patient education programs have reduced stigma around catheter use, encouraging more individuals to seek medical support. The market is also benefiting from innovations in catheter design, such as hydrophilic coatings and silicone materials, which reduce infection risks and enhance patient safety. With urinary incontinence increasingly recognized as a public health concern, healthcare systems are prioritizing accessible and affordable catheter solutions. This trend underscores the critical role of urological catheters in improving quality of life and driving sustained market expansion.

Increasing Adoption of Hydrophilic-Coated Catheters

The growing adoption of hydrophilic‑coated catheters is a key factor propelling the urological catheters market forward. These catheters are designed with a specialized coating that becomes slippery when activated by water, reducing friction during insertion and removal. This feature enhances patient comfort, minimizes urethral trauma, and lowers the likelihood of complications, making them increasingly attractive to both healthcare providers and patients. Hospitals and clinics are prioritizing infection prevention, and hydrophilic coatings help reduce the risk of catheter‑associated infections, which remain a major concern in urological care. Beyond clinical settings, the trend toward self‑catheterization and discreet home‑use devices has accelerated demand for coated catheters, as patients seek safer and more convenient solutions for long‑term management of conditions such as urinary incontinence and benign prostatic hyperplasia. Reimbursement frameworks in developed regions further support their adoption, encouraging healthcare systems to integrate advanced coated devices into routine practice. As innovation continues, manufacturers are focusing on improving durability, biocompatibility, and ease of use, ensuring that hydrophilic‑coated catheters remain central to market growth. This shift reflects a broader movement toward patient‑centric solutions that combine safety, comfort, and efficiency, positioning coated catheters as a cornerstone of the evolving urological devices landscape.

Geographic Insights

North America stands as the largest region in the urological catheters market, primarily due to its advanced healthcare infrastructure, strong reimbursement frameworks, and high patient awareness. The prevalence of chronic urological conditions such as benign prostatic hyperplasia and urinary incontinence, coupled with widespread adoption of self‑catheterization supported by insurance coverage, has created consistent demand. Additionally, stringent infection‑control standards and early adoption of coated and specialty catheters in hospitals further reinforce the region’s leadership. Europe ranks as the second largest region, driven by robust public healthcare systems, regulatory compliance under EU MDR, and strong patient advocacy programs that promote self‑catheterization. Countries such as Germany, France, and the UK contribute significantly, with hospitals emphasizing infection prevention and advanced therapies, while reimbursement policies ensure accessibility across diverse patient groups. Asia Pacific, meanwhile, emerges as the fastest‑growing region, propelled by rapid healthcare expansion, large patient populations, and rising awareness of urological disorders. Government investments in healthcare modernization in China and India, combined with premium adoption in Japan and South Korea, are accelerating demand. The region’s growth is further supported by increasing preference for affordable intermittent catheters in emerging economies and premium coated devices in advanced markets. Collectively, these dynamics highlight North America’s dominance, Europe’s steady maturity, and Asia Pacific’s rapid acceleration, underscoring the need for differentiated strategies tailored to infrastructure, affordability, and innovation across regions.

Market Segmentation

• Based on Product, the market is segmented into Foley catheter, intermittent catheter, and others. The intermittent catheter segment dominated the market in 2024.
• Based on Coating Type, the market is segmented into coated catheters, uncoated catheters. The coated catheters segment dominated the market in 2024.
• Based on Lumen, the market is segmented into single-lumen, multi-lumen. The multi-lumen segment dominated the market in 2024.
• Based on End User, the market is segmented into hospitals & clinics, home care settings, and others. The hospitals & clinics dominated the market in 2024.

Competitive Strategy & Development

Key Players: The Urological Catheters Market is populated by several key players, each contributing to its growth and innovation. Some prominent players are:

1. Medtronic Plc
2. Boston Scientific Corp
3. Becton, Dickinson and Co
4. Teleflex Inc
5. B. Braun SE
6. Nipro Corporation
7. Terumo Corp

Trending Topics: Self-catheterization adoption, Hydrophilic-coated catheter innovation, Silicone catheter demand, Smart catheter technologies, Catheter-associated infection prevention, Postoperative catheter use, Long-term care catheter expansion, Antimicrobial coatings, Discreet home-use devices, EU MDR compliance, aging population impact, BPH-related catheter demand, Urinary incontinence management, Outpatient urology growth, Catheter material advancements, Connected health monitoring, Hospital-acquired infection reduction, Catheterization training programs, Telehealth integration in urology, Sustainability in catheter packaging

Global Headlines

• " FDA-Cleared Lotus Catheter Expands Globally - In October 2025, Lotus Medical Technologies LLC announced global expansion plans for the FDA-cleared Lotus urinary catheter, marking increased international rollout of an indwelling catheter designed for broader clinical use. The device represents a significant innovation in urological catheter design, replacing the traditional Foley catheter’s inflatable balloon with a soft, collapsible wing retention mechanism engineered to reduce trauma and potentially lower infection risk. According to the company’s release, the Lotus Catheter has already been used in over 500,000 clinical cases worldwide. In a peer-reviewed 50-patient study conducted at the University of South Florida, clinicians observed zero catheter-associated urinary tract infections (CAUTIs) among participants using the Lotus system — findings that contrast with the high rates of CAUTIs historically linked to balloon-based indwelling catheters. "

• " FDA Approves Gemcitabine Intravesical System Delivered Via Urinary Catheter for Bladder Cancer - In September 2025, The U.S. Food and Drug Administration (FDA) has granted approval to Inlexzo (gemcitabine intravesical system), a first-of-its-kind intravesical drug delivery system designed to deliver gemcitabine directly into the bladder through a co-packaged urinary catheter and stylet for the treatment of adults with BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with or without papillary tumors."

Conclusion

The urological catheters market is poised for sustained evolution, driven by demographic shifts, clinical demand, and technological innovation. The aging global population and rising prevalence of urinary incontinence and benign prostatic hyperplasia (BPH) continue to fuel the adoption of intermittent catheters, particularly in long-term care and rehabilitation settings. Simultaneously, the growing preference for hydrophilic-coated and silicone-based catheters reflects a broader shift toward infection-resistant, patient-friendly solutions. As healthcare systems prioritize outpatient and home-based care, discreet self-catheterization devices are gaining traction, especially in developed economies where patient autonomy and comfort are paramount. However, the market faces persistent challenges, notably the risk of catheter-associated infections and procedural complications, which underscore the need for rigorous training, improved materials, and smarter clinical protocols. These concerns are catalysing innovation, with manufacturers exploring smart and connected catheter technologies capable of monitoring urine flow and detecting infections in real time. Additionally, expanding use in postoperative recovery and chronic care environments presents a compelling opportunity for product diversification and service integration. As reimbursement models evolve and healthcare delivery decentralizes, success in this market will hinge on balancing affordability with clinical efficacy, supported by robust distribution networks and clinician education. Overall, the urological catheters market is transitioning from commodity-based supply to value-driven care, where innovation, safety, and patient empowerment define competitive advantage.